Literature DB >> 4966821

Accumulation in gram-postive and gram-negative bacteria as a mechanism of resistance to erythromycin.

J C Mao, M Putterman.   

Abstract

Erythromycin was recovered in high yield after incubation with gram-negative bacteria. The cell-free protein-synthesizing preparation from gram-negative bacteria is equally as susceptible to the antibiotic as is that from gram-positive bacteria. Thus, neither destruction of erythromycin nor the absence of the step susceptible to the antibiotic plays an important role in the resistance mechanism of gram-negative bacteria. A 100-fold difference in accumulation of erythromycin between gram-positive and gram-negative bacteria was observed. This alone explains the resistance of gram-negative bacteria to erythromycin. Furthermore, data showed that the inhibition of growth is closely related to the accumulation of erythromycin. The concentration of intracellular erythromycin in gram-positive bacteria was found to be 44- to 90-fold greater than that of the extracellular medium. However, the antibiotic did not accumulate on the cell walls, nor was the accumulation energy-dependent. It is proposed that it takes place by the binding of erythromycin to the bacterial ribosomes, forming a very stable complex. The dissociation constants of erythromycin-Staphylococcus aureus complex and erythromycin-Bacillus subtilis complex were determined to be 1.1 x 10(-7) and 3.4 x 11(-7)m, respectively.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4966821      PMCID: PMC252138          DOI: 10.1128/jb.95.3.1111-1117.1968

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  13 in total

1.  Susceptibility of Proteus mirabilis and its stable L-forms to erythromycin and other macrolides.

Authors:  U TAUBENECK
Journal:  Nature       Date:  1962-10-13       Impact factor: 49.962

2.  The antibacterial action of erythromycin.

Authors:  T H HAIGHT; M FINLAND
Journal:  Proc Soc Exp Biol Med       Date:  1952-10

3.  Sensitivity and resistance to erythromycin in Bacillus subtilis 168: the ribosomal binding of erythromycin and chloramphenicol.

Authors:  S B Taubman; N R Jones; F E Young; J W Corcoran
Journal:  Biochim Biophys Acta       Date:  1966-08-17

4.  Formation of C14-erythromycin-ribosome complex.

Authors:  K Tanaka; H Teraoka; T Nagira; M Tamaki
Journal:  J Biochem       Date:  1966-06       Impact factor: 3.387

5.  Binding of erythromycin to Escherichia coli ribosomes.

Authors:  K Tanaka; H Teraoka
Journal:  Biochim Biophys Acta       Date:  1966-01-18

6.  Demethylation of erythromycins by rabbit tissues in vitro.

Authors:  J C Mao; P L Tardrew
Journal:  Biochem Pharmacol       Date:  1965-07       Impact factor: 5.858

7.  Protein synthesis in a cell-free extract from Staphylococcus aureus.

Authors:  J C Mao
Journal:  J Bacteriol       Date:  1967-07       Impact factor: 3.490

8.  The stoichiometry of erythromycin binding to ribosomal particles of Staphylococcus aureus.

Authors:  J C Mao
Journal:  Biochem Pharmacol       Date:  1967-12       Impact factor: 5.858

9.  Accumulation of label from C14-streptomycin by Escherichia coli.

Authors:  C HURWITZ; C L ROSANO
Journal:  J Bacteriol       Date:  1962-06       Impact factor: 3.490

10.  ERYTHROMYCIN: MODE OF ACTION.

Authors:  A D WOLFE; F E HAHN
Journal:  Science       Date:  1964-03-27       Impact factor: 47.728

View more
  19 in total

Review 1.  Intrinsic and unusual resistance to macrolide, lincosamide, and streptogramin antibiotics in bacteria.

Authors:  R Leclercq; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

2.  Molecular basis of usher pore gating in Escherichia coli pilus biogenesis.

Authors:  Ender Volkan; Vasilios Kalas; Jerome S Pinkner; Karen W Dodson; Nadine S Henderson; Thieng Pham; Gabriel Waksman; Anne H Delcour; David G Thanassi; Scott J Hultgren
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-02       Impact factor: 11.205

3.  Effects of In-Feed Chlortetracycline Prophylaxis in Beef Cattle on Animal Health and Antimicrobial-Resistant Escherichia coli.

Authors:  Getahun E Agga; John W Schmidt; Terrance M Arthur
Journal:  Appl Environ Microbiol       Date:  2016-11-21       Impact factor: 4.792

4.  Macrolide accumulation by Bacteroides fragilis ATCC 25285.

Authors:  Y Muto; K Bandoh; K Watanabe; N Katoh; K Ueno
Journal:  Antimicrob Agents Chemother       Date:  1989-02       Impact factor: 5.191

5.  Novel mechanism for plasmid-mediated erythromycin resistance by pNE24 from Staphylococcus epidermidis.

Authors:  B C Lampson; W von David; J T Parisi
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

6.  Separation of erythromycin-resistant and -susceptible subpopulations of Escherichia coli 15 by partition in two-polymer aqueous phases.

Authors:  L G Wayne; H Walter
Journal:  Antimicrob Agents Chemother       Date:  1974-03       Impact factor: 5.191

7.  Release of (oligo) peptidyl-tRNA from ribosomes by erythromycin A.

Authors:  T Otaka; A Kaji
Journal:  Proc Natl Acad Sci U S A       Date:  1975-07       Impact factor: 11.205

8.  Binding of novel macrolide structures to macrolides-lincosamides-streptogramin B-resistant ribosomes inhibits protein synthesis and bacterial growth.

Authors:  R C Goldman; S K Kadam
Journal:  Antimicrob Agents Chemother       Date:  1989-07       Impact factor: 5.191

9.  Evaluation of three 4"-deoxy-4"-sulfonamido-oleandomycin derivatives with erythromycin-like antibacterial potency.

Authors:  A R English; J A Retsema; A E Girard; W Schelkly; J E Lynch
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

10.  Destruction of the outer membrane permeability barrier of Escherichia coli by heat treatment.

Authors:  T Tsuchido; N Katsui; A Takeuchi; M Takano; I Shibasaki
Journal:  Appl Environ Microbiol       Date:  1985-08       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.